Intravesical Chemotherapy of Superficial Bladder Cancer
- 14 Citations
- 29 Downloads
Abstract
Bladder cancer accounts for 4.4% of the new cases of cancer diagnosed each year in the United States. It was estimated in 1982 that 37,100 new cases of bladder cancer would be seen, with 27,000 cases appearing in males and 10,100 in females [4]. This sex-related dominance is probably a reflection of the preponderance of industrial exposure to chemical carcinogens and cigarette smoking in the male population [21, 22, 25, 85, 92, 106, 169]. These statistics do not include carcinoma in situ. It was also estimated in 1982 that 10,600 deaths would result from bladder cancer [4]. This is a 6% increase in the incidence of bladder cancer and a 3% increase in bladder cancer deaths from 1980 estimates [5]. Histologically, these tumors arise from the bladder epithelium, with transitional cell carcinoma accounting for approximately 90% of the cases, squamous cell carcinomas for 8%, and adenocarcinomas for the remaining 2% [129]. Of these newly diagnosed cases, 75%–85% of patients initially present with superficial (localized) tumors [5]; that is, tumors which would fall into the Jewett-Strong-Marshall classification of stage 0 or A tumors and would be classified at pathologic stage Pa, PIS, or PI in the TNM system [76, 99, 141, 172] (Table 1). These tumors either show no evidence of invasion (0) or invasion of the lamina propria but not the superficial muscle (A).
Keywords
Bladder Cancer Urinary Bladder Bladder Tumor Transitional Cell Carcinoma Bladder CarcinomaPreview
Unable to display preview. Download preview PDF.
References
- 1.Abassian A, Wallace DM (1966) Intracavitary chemotherapy of diffuse non-infiltrating papillary carcinoma of the bladder. J Urol 96:461Google Scholar
- 2.Allen TD, Henderson BW (1965) Adenocarcinoma of the bladder. J Urol 93:50–56PubMedGoogle Scholar
- 3.Althausen AF, Prout GR, Daly JJ (1976) Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ. J Urol 116:575PubMedGoogle Scholar
- 4.American Cancer Society (1982) Cancer Facts and Figures (1981). American Cancer Society, New YorkGoogle Scholar
- 5.American Cancer Society (1980) Cancer statistics. Cancer 30:24Google Scholar
- 6.American Druggist Blue Book (July 1981 – June 1982). Hearst, New YorkGoogle Scholar
- 7.Banks MD, Pontes JE, Izbicki RM, Pierce JM (1977) Topical instillation of doxorubicin hydrochloride in the treatment of recurring superficial transitional cell carcinoma of the bladder. J Urol 118:757–760PubMedGoogle Scholar
- 8.Barnes RW, Bergman RT, Hadley HL, Jonston OL (1967) Control of bladder tumors by endoscopic surgery. J Urol 97: 864PubMedGoogle Scholar
- 9.Barnes RW, Dick AL, Hadley HL, Johnston OL (1977) Survival following transurethral resection of bladder carcinoma. Cancer Res 37:2895–2897PubMedGoogle Scholar
- 10.Becci PJ, Thompson HJ, Grubbs CJ, Brown CC, Moon RC (1979) Effect of delay in administration of 13-cis retinoic acid on the inhibition of urinary bladder carcinogenesis in the rat. Cancer Res 39:3141–3144PubMedGoogle Scholar
- 11.Bessman JD, Johnson RK, Goldin A (1975) Permeability of normal and cancerous rat bladder to antineoplastic agents. Urology 6:187–193PubMedGoogle Scholar
- 12.Bleyer WA (1977) Methotrexate: clinical pharmacology, current status and therapeutic guidelines. Cancer Treat Rev 4:87–101PubMedGoogle Scholar
- 13.Botto H, Perrin JL, Auvert J, Salle M, Pierquin B (1980) Treatment of malignant bladder tumors by iridium-192 wiring. Urology 16:467–469PubMedGoogle Scholar
- 14.Bracken RB, Johnson DE, Rodriguez L, Samuels ML, Ayala A (1977) Treatment of multiple superficial tumors of bladder with intravesical bleomycin. Urology 9:161–163PubMedGoogle Scholar
- 15.Broders AC (1922) Epithelioma of the genitourinary organs. Ann Surg 75:574PubMedGoogle Scholar
- 16.Brown RR, Price JM, Sutter EJ, Wear JB (1960) The metabolism of tryptophan in patients with bladder cancer. Cancer Res 16:299Google Scholar
- 17.Bubenik J, Peremann P, Helmstain K, Moberger G (1970) Cellular and humoral immune responses to human urinary bladder carcinomas. Int J Cancer 5:310PubMedGoogle Scholar
- 18.Burnand KG, Boyd PJR, Mayo ME, Shuttleworth KED, Lloyd-Davies RW (1976) Intravesical thiotepa as an adjuvant to cystodiathermy in the treatment of transitional cell bladder cancer. Br J Urol 48:55–59PubMedGoogle Scholar
- 19.Byar D, Blaekard C (1977) Comparisons of placebo, pyridoxine, and topical thiotepa in preventing recurrence of Stage 1 bladder cancer. Urology 10:556–561PubMedGoogle Scholar
- 20.Camuzzi F, Bondhus M, Lockhart J, Politano V (1980) Mitomycin-C in the treatment of superficial bladder cancer. Am Urol Assn Proc, Abstract 120Google Scholar
- 21.Case RAM, Hosker ME, McDonald DB, Pearson JT (1954) Tumors of the urinary bladder in workmen engaged in the manufacture and use of certain dye stuffs intermediates in the British chemical industry. The role of aniline, benzidine, alpha-naphthylamine, and beta-naphthylamine. Br J Ind Med 11:75PubMedGoogle Scholar
- 22.Case RAM, Hosker ME (1954) Tumor of the urinary bladder as an occupational disease in the rubber industry in England and Wales. Br J Prev Soc Med 8: 39–50PubMedGoogle Scholar
- 23.Chan RC, Bracken RB, Johnson DE (1979) Single dose whole pelvis megavoltage irradiation for palliative control of hematuria or ureteral obstruction. J Urol 122:750–751PubMedGoogle Scholar
- 24.Cohen SM, Wittenberg JF, Bryan GT (1974) Effect of hyper- and avitaminosis A on urinary bladder carcinogenicity of N-(4-(5-nitro-2-furyl)-2-thiazolyl)-formamide (FANT). Fed Proc 33:602Google Scholar
- 25.Cole P, Hoover R, Friedell GH (1972) Occupation and cancer of the lower urinary tract. Cancer 29:1250PubMedGoogle Scholar
- 26.Colleen S, Ek A, Hellsten S, Lindholm CE (1980) Intracavitary Epodyl for multiple, non-invasive highly differentiated bladder tumors. Scand J Urol Nephrol 14:43–45PubMedGoogle Scholar
- 27.Connolly JG, Anderson C, Johnson I (1979) Some newer approaches to the treatment of the mucosa of patients with superficial bladder cancer: 1. Continuous bladder irrigation with 5-fluorouracil. Can Med Assoc J 121:318–320PubMedGoogle Scholar
- 28.Cooper PH, Waisman J, Johnston WH, Skinner DG (1973) Severe atypia of transitional epithelium and carcinoma of the urinary bladder. Cancer 31:1055PubMedGoogle Scholar
- 29.Corder MP, Stamp DC (1982) Chemotherapeutic approaches to transitional cell carcinoma of the bladder: part 1, superficial disease; chemoprevention. In: Bonney WW, Prout GR (eds) AUA Monographs, vol 1, bladder cancer. Williams and Wilkins, Baltimore, pp 165–172Google Scholar
- 30.Cox CE, Cass AS, Boyce WH (1968) Bladder cancer: a 26 year review. Trans Am Assoc Genitourin Surg 60:22–30PubMedGoogle Scholar
- 31.Day JW, Shrivastav S, Lin G, Bonar RA, Paulson DF (1981) In vitro chemotherapeutic testing of urologic tumors. J Urol 125:490–492PubMedGoogle Scholar
- 32.De Furia MD, Bracken RB, Johnson DE, Soloway MS, Merrin LE, Morgan LR, Miller HC, Crooke ST (1980) Phase I—II study of Mitomycin C topical therapy for low grade, low stage transitional cell carcinoma of the bladder: an interim report. Cancer Treat Rep 64:225–230Google Scholar
- 33.Dean AC, Mostofi FK, Thomason RV, Clark ML (1954) A restudy of the first 1400 tumors in the bladder tumor registry. AFIP J Urol 71:571–590Google Scholar
- 34.Denning CL (1950) The biological behavior of transitional cell papilloma of the bladder. J Urol 63:815–819Google Scholar
- 35.Dickson RJ, Lang EK (1960) Treatment of papillomata of the bladder with radioactive colloidal gold (Au198) Am J Roentgen 83:116PubMedGoogle Scholar
- 36.Dorr RT, Fritz WL (1980) Cancer chemotherapy handbook. Elsevier-Holland, New YorkGoogle Scholar
- 37.Douville Y, Pelouze G, Roy R, Charrois R, Kibrite A, Martin M, Dionne L, Coulonval L, Robinson J (1978) Recurrent bladder papillomata treated with bacillus Calmette-Guerin: a preliminary report. Cancer Treat Rep 62:551PubMedGoogle Scholar
- 38.Drew JE, Marshall VF (1968) The effects of topical thiotepa on the recurrence rate of superficial bladder cancer. J Urol 99:740–743PubMedGoogle Scholar
- 39.Duckworth DA (1950) The treatment of papillomatosis with podophyllin. J Urol 64:740PubMedGoogle Scholar
- 40.Durrant KR, Laing AH (1975) Treatment of multiple superficial papillary tumors of the bladder by intracavitary Yttrium-99. J Urol 113:480–482PubMedGoogle Scholar
- 41.Edsmyr F, Boman J (1970) Instillation of thiotepa in vesical papillomatosis. Acta Radiol [Ther] (Stockh) 9:395–400Google Scholar
- 42.Edsmyr F, Berlin T, Boman J, Duchek M, Eposti PL, Gustafsson H, Wijkstrom H, Collste LG (1980) Intravesical therapy with adriamycin in patients with superficial bladder tumors. Eur Urol 6:132–136PubMedGoogle Scholar
- 43.Einhorn J, Hultzberg S, Nilson A (1964) Treatment of papillomatosis of the bladder with radioactive arsenic 76As. Acta Radiol Ther 2:1–16Google Scholar
- 44.Eisenberg RB, Roth RB, Schweinsberg MH (1960) Bladder tumors and associated proliferative mucosal lesions. J Urol 84:544PubMedGoogle Scholar
- 45.Eksborg S, Nilsson S, Edsmyr F (1980) Intravesical instillation of adriamycin: a model for standardization of the chemotherapy. Eur Urol 6:218–220PubMedGoogle Scholar
- 46.England HR, Rigby C, Shepheard BGF, Tresidder GC, Blandy JP (1973) Evaluation of Helmstein’s distension method for carcinoma of the bladder. Br J Urol 45:593PubMedGoogle Scholar
- 47.Esquivel EL, MacKenzie R, Whitmore WF (1965) Treatment of bladder tumors by instillation of thiotepa, actinomycin D, or 5-fluorouracil. Invest Urol 2:381–386PubMedGoogle Scholar
- 48.Farrow GM, Utz DC, Rite CC (1976) Morphological and clinical observations of patients with early bladder cancer treated with total cystectomy. Cancer Res 36:2495PubMedGoogle Scholar
- 49.Farrow GM, Utz DC, Rite CC, Greene LF (1977) Clinical observation on 69 cases of in situ carcinoma of the urinary bladder. Cancer Res 37:2794–2798PubMedGoogle Scholar
- 50.Fitzpatrick JM, Khan O, Oliver RTD, Riddle PR (1979) Long term follow-up in patients with superficial bladder tumors treated with intravesical Epodyl. Br J Urol 51:545–548PubMedGoogle Scholar
- 51.Flocks RH (1951) Treatment of patients with carcinoma of the bladder. JAMA 145:295–301Google Scholar
- 52.Franksson C (1950) Tumors of the urinary bladder: a pathological and clinical study of 434 cases. ACTA Chir Scand [Suppl] 515:1–203Google Scholar
- 53.Gavrell GJ, Lewis RW, Meehan WL, Leblanc GA (1978) Intravesical thiotepa in the immediate postoperative period in patients with recurrent transitional cell carcinoma of the bladder, J Urol 120:410–411PubMedGoogle Scholar
- 54.Gowing NFC (1960) Urethral carcinoma associated with cancer of the bladder. Br J Urol 32:428–439PubMedGoogle Scholar
- 55.Greene LF, Hanash KA, Farrow GM (1973) Benign papilloma or papillary carcinoma of the bladder? J Urol 110:205PubMedGoogle Scholar
- 56.Hall RR, Bloom HJG, Freeman JE, Nawrocki A, Wallace DM (1974) Methotrexate treatment for advanced bladder cancer. Br J Urol 46:431–438PubMedGoogle Scholar
- 57.Hall RR, Shade RO, Swinney J (1974) Effects of hyperthermia on bladder cancer. Br Med J 2:593–594PubMedGoogle Scholar
- 58.Hall RR, Herring DW, McGill AC, Gibb I (1981) Oral methotrexate therapy for multiple superficial bladder carcinomata. Cancer Treat Rep 65 (Suppl 1): 175–178PubMedGoogle Scholar
- 59.Hendry WF, Gowing NFC, Wallace DM (1974) Surgical treatment of urethral tumors associated with bladder cancer. Proc R Soc Med 67:304PubMedGoogle Scholar
- 60.Herring HT (1903) The treatment of vesical papilloma by injections. Br Med J 2:1398PubMedGoogle Scholar
- 61.Hicks RM (1966) The permeability of rat transitional cell epithelium. J Cell Biol 28:21PubMedGoogle Scholar
- 62.Hinman F (1956) Recurrence of bladder tumors by surgical implantation. J Urol 75:695–696PubMedGoogle Scholar
- 63.Hirose K, Seto T, Takayasu H (1977) Re-evaluation of hydrostatic pressure treatment for malignant bladder lesions. J Urol 118:762PubMedGoogle Scholar
- 64.Hisazumi H, Uchibayashi T, Naito K, Misaki T, Miyazaki K (1975) The prophylactic use of thiotepa and urokinase in transitional cell carcinoma of the bladder: a preliminary report. J Urol 114:394PubMedGoogle Scholar
- 65.Hollands FG (1950) The results of diathermy treatment of villous papilloma of the bladder. Br J Urol 22:342–375PubMedGoogle Scholar
- 66.Hollister D, Coleman M (1980) Hematologic effects of intravesicular thiotepa therapy for bladder carcinoma. JAMA 244:2065–2067PubMedGoogle Scholar
- 67.Horn Y, Eidelman A, Walach N, Ilian M (1981) Intravesical chemotherapy in a controlled trial with thiotepa versus doxorubicin hydrochloride. J Urol 125: 652–654PubMedGoogle Scholar
- 68.Issel BF, DeFuria MD, Fandrich SE (1981) Topical mitomycin-C in thiotepa refractory non-invasive bladder cancer. Am Soc Clin Oncol Proc 22:464Google Scholar
- 69.Jacobi GH, Kurth KH, Klippel KF, Hohenfellner R (1978) On the biological behavior of T2 transitional cell tumors of the urinary bladder and initial results of the prophylactic use of topical adriamycin under controlled and randomized conditions. In: WHO, Diagnostics and treatment of superficial urinary bladder tumors. Collaborating centre for research and treatment of bladder cancer, Stockholm, pp 83–94Google Scholar
- 70.Jacobi GH, Kurth K (1980) Studies on the intravesical action of topically administered G3H-doxorubicin hydrochloride in men: plasma uptake and tumor penetration. J Urol 124:34–37PubMedGoogle Scholar
- 71.Jacobi GH, Jaske G, Thuroff JW, Bauer HW (1981) Intravesical chemotherapy for prophylaxis of recurrent superficial bladder tumors: a randomized trial of 122 patients. Am Urol Assn Meeting Abstract 579Google Scholar
- 72.Jacobo E, Loening S, Schmidt JD, Culp DA (1977) Primary adenocarcinoma of the bladder: a retrospective study of 20 patients. J Urol 117:54–56PubMedGoogle Scholar
- 73.Jaske G, Hofstadter F (1980) Intravesical doxorubicin hydrochloride in the management of carcinoma in situ of the bladder. Eur Urol 6:103–106Google Scholar
- 74.Jaske G (1981) Intracavitary doxorubicin hydrochloride treatment for carcinoma in situ of the urinary bladder. Eur Urol 7:68–72Google Scholar
- 75.Jaske G, Hofstadter F, Marberger H (1981) Intracavitary doxorubicin hydrochloride therapy for carcinoma in situ of the bladder. J Urol 125:185–189Google Scholar
- 76.Jewett HJ, Strong GH (1946) Infiltrating carcinoma of the bladder. Relation of depth of penetration of the bladder wall to incidence of local extension and metastasis. J Urol 55:366PubMedGoogle Scholar
- 77.Johnson DE, Schaenwald MB, Ayala AG, Miller LS (1976) Squamous cell carcinoma of the bladder. J Urol 115:542–544PubMedGoogle Scholar
- 78.Jones HC, Swinney J (1961) Thiotepa in the treatment of tumors of the bladder. Lancet 2:615PubMedGoogle Scholar
- 79.Joseph E (1919) Eine neue Methode zur Behandlung der Blasengeschwulste, vorläufige Mitteilung. Zentralbl Chir 46:931Google Scholar
- 80.Kaufman JJ, Walthur PJ, Smith RB, Skinner DG (1979) Intracavitary Mitomycin-C in the treatment of superficial urothelial tumors: a preliminary report. Trans Am Assoc Genitourin Surg 71: 6–7PubMedGoogle Scholar
- 81.Kerr IG, Lippman M, Jenkins J, Meyers C (1981) Clinical pharmacology of 13-cis-retinoic acid. Proc Am Soc Clin Oncol 22:357 AbstractGoogle Scholar
- 82.Keiter JH (1953) Bladder tumor recurrences in the urethra: a warning. J Urol 60: 652–656Google Scholar
- 83.Koontz WW (1979) Intravesical chemotherapy and chemoprevention of superficial, low grade, low stage bladder carcinoma. Semin Oncol 6:217–219PubMedGoogle Scholar
- 84.Koontz WW, Prout GR, Smith W, Frable WJ, Minnis JE (1981) The use of intravesical thiotepa in the management of non-invasive carcinoma of the bladder. J Urol 125:307–312PubMedGoogle Scholar
- 85.Koss LG, Melamed MR, Kelly RE (1969) Further cytologic and histologic studies of bladder lesions in workers exposed to para-aminodiphenyl: progress report. J Natl Cancer Inst 43:233–243PubMedGoogle Scholar
- 86.Koss LG (1977) Some ultrastructural aspects of experimental and human carcinoma of the bladder. Cancer Res 37:2824PubMedGoogle Scholar
- 87.Koss LG, Tiamson EM, Robbins MA (1974) Mapping cancerous and precancerous bladder changes. A study of the urothelium in ten surgically removed bladders. JAMA 227:281PubMedGoogle Scholar
- 88.Lamm DL, Harris SC, Gittes RF (1977) Bacillus Calmette-Guerin and dinitrochloro- benzene immunotherapy of chemically induced bladder tumors. Invest Urol 14:369PubMedGoogle Scholar
- 89.Lamm DL, Thor DE, Winters WD, Stogdill VD, Radwin HM (1981) BCG immunotherapy of bladder cancer: inhibition of tumor recurrence and associated immune responses. Cancer 38:82–88Google Scholar
- 90.Leissner K, Gustavsson B, Nilsson S, Almersjo O (1978) General resorption of intravesically instilled 5-fluorouracil. J Urol 120:407–409PubMedGoogle Scholar
- 91.Lerman RI, Hutter RVP, Whitmore WF (1970) Papilloma of the urinary bladder. Cancer 25:333–342PubMedGoogle Scholar
- 92.Lilienfeld AM (1964) The relationship of bladder cancer to smoking. Am J Public Health 54:1864Google Scholar
- 93.Loening S, Narayana A, Yoder L, Slyman D, Weinstein S, Penick G, Culp D (1980) Factors influencing the recurrence rate of bladder cancer. J Urol 123:29PubMedGoogle Scholar
- 94.Lundbeck F, Pederson D, Stroyer I, Uldall A (1981) Absorption of doxorubicin hydrochloride during bladder washings in treatment of non-invasive bladder tumors. Urology 18:161–163PubMedGoogle Scholar
- 95.Lutzeyer W, Rubben H, Dahm H (1982) Prognostic parameters in superficial bladder cancer: an analysis of 315 cases. J Urol 127:250–252PubMedGoogle Scholar
- 96.MacKenzie N, Torti FM, Faysal M (1981) The natural history of superficial bladder tumors. Proc Am Assoc Cancer Res 22:198Google Scholar
- 97.Maluf NSR (1953) Absorption of water, urea, glucose and electrolytes through the human bladder. J Urol 98:470Google Scholar
- 98.Marberger J, Marberger M, Decristoforo A (1972) The current status of transurethral resection in the diagnosis and therapy of carcinoma of the urinary bladder. Int J Urol Nephrol 4:35–44Google Scholar
- 99.Marshall VF (1952) The relation of the preoperative estimate to the pathologic demonstration of the extent of vesical neoplasm. J Urol 68:714PubMedGoogle Scholar
- 100.Wade A, Reynolds JEF (eds) (1977) Martindales: the extra pharmacopia, 27th edn. Pharmaceutical Press, LondonGoogle Scholar
- 101.Martinez-Pineiro JA, Muntanola P (1977) Non-specific immunotherapy with BCG vaccine in bladder tumors: a preliminary report. Eur Urol 3:11PubMedGoogle Scholar
- 102.McDonald DF, Thorsen T (1956) Clinical implications of transplantability of induced bladder tumors to intact transitional epithelium in dogs. J Urol 75:690PubMedGoogle Scholar
- 103.Melicow MM (1952) Histological study of vesical urothelium intervening between gross neoplasms in total cystectomy. J Urol 68:261PubMedGoogle Scholar
- 104.Melicow MM (1955) Tumor of the urinary bladder, a clinicopathological analysis of over 2500 specimens and biopsies. J Urol 74:498–521PubMedGoogle Scholar
- 105.Melicow MM (1978) The urothelium: a battleground for oncogenesis. J Urol 120:43PubMedGoogle Scholar
- 106.Miller AB (1977) The etiology of bladder cancer from the epidemiological viewpoint. Cancer Res 37:2939–2942PubMedGoogle Scholar
- 107.Milner WA (1954) The role of conservative surgery in the treatment of bladder tumors. Br J Urol 26:375–384PubMedGoogle Scholar
- 108.Mishina T, Oda K, Murata S, Ooe H, Yasuyuki M, Takahashi T (1975) Mitomycin-C bladder instillation therapy for bladder tumors. J Urol 114:217–219PubMedGoogle Scholar
- 109.Mishina T, Watanabe H (1979) Mitomycin-C bladder instillation therapy for bladder tumors. In: Carter SK, Crooke ST (eds) Mitomycin-C: current status and new developments. Academic, New York, pp 193–203Google Scholar
- 110.Mitchell RJ (1971) Intravesical thiotepa in the treatment of transitional cell bladder carcinoma. Br J Urol 43:185–188PubMedGoogle Scholar
- 111.Morales A, Eidinger D, Bruce AW (1976) Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol 116:180PubMedGoogle Scholar
- 112.Morales A (1978) Adjuvant immunotherapy in superficial bladder cancer. Natl Cancer Inst Monogr 49: 315–319PubMedGoogle Scholar
- 113.Morales A, Eidinger D, Bruce AW (1976) Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol 116:180–183PubMedGoogle Scholar
- 114.Morales A (1980) Treatment of carcinoma in situ of the bladder with BCG: a phase II trial. Cancer Immunol Immunother 9:69–72Google Scholar
- 115.Morales A, Ottenhof P, Emerson L (1981) Treatment of residual, noninfiltrating bladder cancer with bacillus Calmette-Guerin. J Urol 125:649–651PubMedGoogle Scholar
- 116.Murphy WM, Soloway MS, Finebaum PJ (1981) Pathological changes associated with topical chemotherapy for superficial bladder cancer. J Urol 126:461–464PubMedGoogle Scholar
- 117.Murphy W, Nagy GK, Rao MK, Soloway MS, Parija GC, Cox CE, Friedell GH (1979) Normal urothelium in patients with bladder cancer. Cancer 44:1050PubMedGoogle Scholar
- 118.Nakazono M, Iwata S (1978) A preliminary study of chemotherapeutic treatment for bladder tumors. J Urol 119:598–600PubMedGoogle Scholar
- 119.Natale RB, Yagoda A, Watson RC, Whitmore WF, Blumenreich M, Braun DW (1981) Methotrexate: an active drug in bladder cancer. Cancer 47:1246–125PubMedGoogle Scholar
- 120.NCI Investigational Drugs: Pharmaceutical Data 1981, Pharmaceutical Resources Branch, Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute, US Dept of Health and Human Services, National Institutes of Health, Washington DC, p 91Google Scholar
- 121.Needles B, Blumenreich M, Yagoda A, Sogani P, Whitmore WF (1981) Intravesical cisplatin for superficial bladder cancer. Am Assoc Cancer Res 22:158Google Scholar
- 122.Nichols JA, Marshall VF (1956) Treatment of histologically benign papilloma of the urinary bladder by local excision and fulguration. Cancer 9:566–567PubMedGoogle Scholar
- 123.Nieh PT, Daly JJ, Heaney JA, Heney NM, Prout GM (1978) The effect of intravesical thiotepa on normal and tumor urothelium. J Urol 119:59–61PubMedGoogle Scholar
- 124.Nielsen HV, Thybo E (1979) Epodyl treatment of bladder tumors. Scand J Urol Nephrol 13:59–63PubMedGoogle Scholar
- 125.Niijima T (1978) Intravesical therapy with adriamycin and new trends in the diagnostics and therapy of superficial bladder tumors. In: WHO, Diagnostics and treatment of superficial urinary bladder tumors. Collaborating centre for research and treatment of urinary bladder cancer, Stockholm, pp 37–44Google Scholar
- 126.Nissenkorn I, Herrod H, Soloway MS (1981) Side effects associated with intravesical Mitomycin-C. J Urol 126:586–587Google Scholar
- 127.Nocks BN, Nieh PT, Prout GR (1979) A longitudinal study of patients with superficial bladder carcinoma. J Urol 122:27–29PubMedGoogle Scholar
- 128.O’Flynn JD, Smith M, Hanson JS (1975) Transurethral resection for the assessment and treatment of vesical neoplasms. Eur Urol 1:38–40PubMedGoogle Scholar
- 129.Olsson CA, DeVere-White RW (1979) Cancer of the bladder In: Javadpour N (ed) Principles and management of urologie cancer. Williams and Wilkins, BaltimoreGoogle Scholar
- 130.Oravisto KJ (1965) Topical use of thiotepa for tumors of the bladder. Urol Int 20:23–38PubMedGoogle Scholar
- 131.Page BH, Levison V, Curwen MP (1979) A trial of prophylactic radiotherapy for non-infiltrating bladder tumors. Br J Urol 51:197–199PubMedGoogle Scholar
- 132.Pavone-Macaluso M (1971) Chemotherapy of vesical and prostatic tumors. Br J Urol 43:701–708PubMedGoogle Scholar
- 133.Pavone-Macaluso M, Caramia G (1972) Adriamycin and daunomycin in the treatment of vesical and prostatic neoplasias: preliminary results. In: Carter SK, DiMarco A, Ghione M, Krakoff IH, Mathe G (eds) International symposium on adriamycin. Springer, Berlin Heidelberg New York, p 180Google Scholar
- 134.Pavone-Macaluso M, Gebbia N, Biondo F, Bertitolini S, Caramia G, Rizzo FP (1976) Permeability of the bladder mucosa to thiotepa, adriamycin, and daunomycin in men and rabbits. Urol Res 4:9PubMedGoogle Scholar
- 135.Pavone-Macaluso M (1978) Intravesical treatment of superficial (Tl) urinary bladder tumors: a review of a 15-year experience. In: WHO, Diagnostics and treatment of superficial urinary bladder tumors. Collaborating centre for research and treatment of urinary bladder cancer, Stockholm, pp 21–36Google Scholar
- 136.Pavone-Macaluso M, Ingaugiola GB (1980) Local chemotherapy in bladder cancer treatment. Oncology [Suppl] 37:71–76PubMedGoogle Scholar
- 137.Peck GL, Yoder FW (1976) Treatment of lamellar ichthyosis and other keritinising dermatosis with an oral synthetic retinoid. Lancet 2:1172–1173PubMedGoogle Scholar
- 138.Poole-Wilson DS, Barnard RJ (1971) Total cystectomy for bladder tumors. Br J Urol 43:16PubMedGoogle Scholar
- 139.Presant CA, Bearman R, Bartolucci A, Lefant J (1981) Randomized study of 13-cis-retinoic acid (RA) plus busulfan (B) or B alone in chronic phase chronic granulocytic leukemia. Proc Am Soc Clin Oncol 22:488 AbstractGoogle Scholar
- 140.Prout GR, Cox E, Cummings KB, Flanagan MJ, Friedell GH, Hodges CV, Koontz WW, Merrin CEA, Schmidt JD, Veenema RJ, Warram JH (1977) Surveillance, initial assessment and subsequent progress of patients with superficial bladder cancer in a prospective longitudinal study. Cancer Res 37:2907Google Scholar
- 141.Prout GR (1977) Bladder carcinoma and a TNM system of classification. J Urol 117:583PubMedGoogle Scholar
- 142.Prout GR, Griffin PP, Nocks BN (1981) Intravesical therapy of low stage bladder carcinoma with mitomycin-C: comparison of results in untreated and previously treated patients. Am Urol Assn Proc Abstract 437Google Scholar
- 143.Pyrah LN, Raper FP, Thomas GM (1964) Report of a follow-up of papillary tumors of the bladder. Br J Urol 36:14PubMedGoogle Scholar
- 144.Riddle PR (1978) Pre-organized intervention concerning Epodyl treatment. Proceedings of the second course on urologic oncology, E Hore Majorana, Erice TrapaniGoogle Scholar
- 145.Riddle PR, Wallace DM (1971) Intracavitary chemotherapy for multiple non-invasive bladder tumors. Br J Urol 43:181–184PubMedGoogle Scholar
- 146.Riddle PR (1973) The management of superficial bladder tumors with intravesical epodyl. Br J Urol 45:84–87PubMedGoogle Scholar
- 147.Riddle PR, Chisholm GD, Trott PA, Pugh RCB (1976) Flat carcinoma in situ of bladder. Br J Urol 47:829–833Google Scholar
- 148.Robinson MRG, Shetty MB, Richards B, Bastable J, Glashan RW, Smith PH (1977) Intravesical epodyl in the management of bladder tumors: combined experience of the Yorkshire Urologic Cancer Research Group. J Urol 118:972–973PubMedGoogle Scholar
- 149.Rozencweig M, Von Hoff DD, Henneny JE, Muggia FM (1977) VM-26 and VP-16–213: a comparative analysis. Cancer 40:334–342PubMedGoogle Scholar
- 150.Rubben H, Dahm HH, Lutzeyer W (1981) Frequency of recurrences and tumor progression of superficial bladder carcinomas. Urologe [A] 20:211–214Google Scholar
- 151.Russell M (1963) Treatment of papillary tumor of bladder with chloropactin XCB (oxochlorosene): a preliminary report. J Urol 89:188PubMedGoogle Scholar
- 152.Sadoughi N, Johnson RA, Ezdinli EZ, Bush IM, Guinan P (1973) Intravesical bleomycin in treatment of carcinoma of the bladder. J Am Med Assoc 226:465Google Scholar
- 153.Schade ROK, Swinney J (1973) The association of urothelial atypism with neoplasia: its importance in treatment and prognosis. J Urol 109:619PubMedGoogle Scholar
- 154.Schellhammer PF, Bean MA, Whitmore WF (1977) Prostatic involvement by transitional cell carcinoma: pathogenesis, patterns, and prognosis. J Urol 118:399PubMedGoogle Scholar
- 155.Schulman CC, Denis LJ, Oosterlinck W, DeSy W, Chantrie M, VanCangh PJ (1981) Early adjuvant adriamyein in superficial bladder cancer. Am Urol Assn Meeting, Abstract 436Google Scholar
- 156.Schulman C, Sylvester R, Robinson M, Smith P, Lachand A, Denis L, Pavone-Macaluso M, De Pavio M, Staquet M (1982) Adjuvant therapy of T1 bladder carcinoma: preliminary results in an EORTC randomized study. Urol Res (in press)Google Scholar
- 157.Semple JE (1948) Papillomata of the bladder treated with podophyllin. Br Med J 1:1235PubMedGoogle Scholar
- 158.Seemayer TA, Knaack J, Thelmo WC (1975) Further observations on carcinoma in situ of the urinary bladder: silent but extensive intraprostatic involvement. Cancer 36:514PubMedGoogle Scholar
- 159.Smith IM, Lane V, O’Flynn JD (1978) Epodyl in management of noninvasive vesical neoplasms. Urology 11:474–477PubMedGoogle Scholar
- 160.Smith PH, McCollum CN (1976) Intravesical bleomycin in bladder cancer. J Am Med Assoc 235:906–907Google Scholar
- 161.Soloway MS (1977) Intravesical and systemic chemotherapy of murine bladder cancer. Cancer Res 37:2918–2929PubMedGoogle Scholar
- 162.Soloway MS, Murphy W, Rao MK (1978) Serial multiple site biopsies in patients with bladder cancer. J Urol 120:57PubMedGoogle Scholar
- 163.Soloway MS (1980) Rationale for intensive intravesical chemotherapy for superficial bladder cancer. J Urol 123:461–466PubMedGoogle Scholar
- 164.Soloway MS, Murphy WM, DeFuria MD (1981) Intravesical mitomycin-C in superficial bladder cancer. Am Soc Clin Oncol Proc 22:469Google Scholar
- 165.Soto EA, Friedell GH, Tiltman AJ (1977) Bladder cancer as seen in giant histologic sections. Cancer 39:447PubMedGoogle Scholar
- 166.Sporn MB, Kunlop NM, Newton DL, Smith JM (1976) Prevention of chemical carcinogenesis by Vitamin A and its synthetic analogs (retinoids). Fed Proc 35:1332–1338PubMedGoogle Scholar
- 167.Sporn MB, Squire RA, Brown CC, Smith JM, Wenk ML, Springer S (1977) 13-cis-retinoic acid: inhibition of bladder carcinogenesis in the rat. Science 195:487–489Google Scholar
- 168.Squire RA, Sporn MB, Brown CC, Smith JM, Wenk ML, Springer S (1977) Histopathological evaluation of the inhibition of rat bladder carcinogenesis by 13-cis-re- tinoic acid. Cancer Res 37:2930–2936PubMedGoogle Scholar
- 169.Swartz D, Flamant R, Lellouch J, Denoix PF (1961) Results of a French survey on the role of tobacco, particularly inhalation, in different cancer sites. J Natl Cancer Inst 26:1085Google Scholar
- 170.Thompson N (1960) Bladder papilloma: an analysis of 75 cases. Br J Surg 47: 419–424PubMedGoogle Scholar
- 171.Turner AG, Hendry WF, Williams GB, Bloom HJG (1977) The treatment of advanced bladder cancer with methotrexate. Br J Urol 49:673–678PubMedGoogle Scholar
- 172.Union Internationale Contre le Cancer (1974) TNM classification of malignant tumors, de Buren, GenevaGoogle Scholar
- 173.Utz DC, Hanash KA, Farrow GM (1970) The plight of the patient with carcinoma in situ of the bladder. J Urol 103:160PubMedGoogle Scholar
- 174.Utz DC, Farrow GM, Rife CC, Segura JW, Zincke H (1980) Carcinoma in situ of the bladder. Cancer 45:1842–1848PubMedGoogle Scholar
- 175.Uyama T, Moriwaki S, Nakamura S, Kagawa S (1980) Intravesical instillation of adriamycin combined with low-dose irradiation for superficial bladder cancer. Urology 15:584–587PubMedGoogle Scholar
- 176.Van der Werf-Messing B (1978) Cancer of the urinary bladder treated by interstitial radium implant. Int J Radiat Oncol Biol Phys 4:373–378PubMedGoogle Scholar
- 177.Van der Werf-Messing B (1969) Carcinoma of the bladder treated by suprapubic radium implants. Eur J Cancer 5:277–285PubMedGoogle Scholar
- 178.Van der Werf-Messing B, Hop WCJ (1981) Carcinoma of the urinary bladder (category T1 Nx Mo) treated either by radium implant or by transurethral resection only. Int J Radiat Oncol Biol Phys 7:299–303PubMedGoogle Scholar
- 179.Varhavakis MJ, Gaeta J, Moore RH, Murphy GP (1974) Superficial bladder tumor, aspects of clinical progression. Urology 4:414Google Scholar
- 180.Veenema RJ, Dean AL, Roberts M, Fingerhut B, Chowhury BK, Tarassoly H (1962) Bladder carcinoma treated by direct instillation of thiotepa. J Urol 88:60–63PubMedGoogle Scholar
- 181.Veenema RJ, Dean AL, Uson AC, Roberts M, Longo F (1969) Thiotepa bladder instillations: therapy and prophylaxis for superficial bladder tumors. J Urol 101: 711–715PubMedGoogle Scholar
- 182.Wallace AC, Herschfield ES (1958) The experimental implantation of tumor cells in the urinary tract. Br J Cancer 12:622PubMedGoogle Scholar
- 183.Wallace DM (1971) Intracavitary radiation for multiple non-infiltrating bladder tumors. Br J Urol 43:177–130PubMedGoogle Scholar
- 184.Wallace DM, Hindmarsh JR, Webb JN, Busuttil A, Hargreave TB, Newsam JE, Chisholm GD (1979) The role of multiple mucosal biopsies in the management of patients with bladder cancer. Br J Urol 51:535–540PubMedGoogle Scholar
- 185.Weldon TE, Soloway MS (1975) Susceptibility of urothelium to neoplastic cellular implantation. Urology 5: 824PubMedGoogle Scholar
- 186.Westcott JW (1966) The prophylactic use of thiotepa in transitional cell carcinoma of the bladder. J Urol 96:913–918Google Scholar
- 187.Whitmore WF (1979) Surgical management of low stage bladder cancer. Semin Oncol 61:207–216Google Scholar
- 188.Williams JC, Hammonds JC, Saunders N (1977) T1 bladder tumors. Br J Urol 49: 663PubMedGoogle Scholar
- 189.Winters WD, Lamm DL (1981) Antibody response to bacillus Calmette-Guerin during immunotherapy in bladder cancer patients. Cancer Res 41:2672–2676PubMedGoogle Scholar
- 190.Yagoda A (1980) Chemotherapy of metastatic bladder cancer. Cancer 45:1879–1888PubMedGoogle Scholar
- 191.Yoshida O, Brown RR, Bryan GT (1970) Relationship between tryptophan metabolism and heterotopic recurrences of human urinary bladder tumors. Cancer 25:773PubMedGoogle Scholar